Are changes in the pharmacokinetic (PK) and pharmacodynamic (PD) properties of antipsychotics able to improve efficacy and safety
- Luca Pani
DOIAbstract
Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here
Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here
Background and objectives: The superiority of atypical antipsychotics (also known as second-generati...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
The pharmacological treatment of schizophrenia has made great strides in the last few decades. Many ...
The pharmacological treatment of schizophrenia has made great strides in the last few decades. Many ...
Olanzapine is one of the most widely used antipsychotics since its initial approval by the US Food a...
Objectives: To link the brain dopamine D2 receptor occupancy (D2RO) of antipsychotic drugs with clin...
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, relat...
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, relat...
Objectives: To link the brain dopamine D2 receptor occupancy (D2RO) of antipsychotic drugs with clin...
Previously, clinicians worked with antipsychotic drugs that almost invariably caused extrapyramidal ...
Background: To develop a pharmacokinetic-pharmacodynamic (PK-PD) model using individual-level data o...
Maximilian Gahr1,*, Markus A Kölle1,*, Carlos Schönfeldt-Lecuona1, Peter Lepping2,...
A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly ...
A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly ...
Background and objectives: The superiority of atypical antipsychotics (also known as second-generati...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
The pharmacological treatment of schizophrenia has made great strides in the last few decades. Many ...
The pharmacological treatment of schizophrenia has made great strides in the last few decades. Many ...
Olanzapine is one of the most widely used antipsychotics since its initial approval by the US Food a...
Objectives: To link the brain dopamine D2 receptor occupancy (D2RO) of antipsychotic drugs with clin...
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, relat...
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, relat...
Objectives: To link the brain dopamine D2 receptor occupancy (D2RO) of antipsychotic drugs with clin...
Previously, clinicians worked with antipsychotic drugs that almost invariably caused extrapyramidal ...
Background: To develop a pharmacokinetic-pharmacodynamic (PK-PD) model using individual-level data o...
Maximilian Gahr1,*, Markus A Kölle1,*, Carlos Schönfeldt-Lecuona1, Peter Lepping2,...
A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly ...
A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly ...
Background and objectives: The superiority of atypical antipsychotics (also known as second-generati...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
Novel formulations and new routes of administration for psychotropic drugs can offer advantages over...
Add to ORKG